Leadership in Hybrid Customer Engagements
The intent of this webinar is to have a discussion on which strategies are working, and how leading companies are defining success for field medical teams in hybrid engagements.
The intent of this webinar is to have a discussion on which strategies are working, and how leading companies are defining success for field medical teams in hybrid engagements.
The growth of Real-World Evidence (RWE) from sources including patient registries, claims data, electronic medical records, digital health technologies and more has powered the ability of Medical Affairs to drive patient outcomes. Here, the MAPS Executive Consortium describes how.
MAPS is pleased to share our 2023 Medical Metrics Benchmarking Report, based on findings from 51 leading organizations representing the Pharmaceutical, Biotech, and Medical and Diagnostic Device sectors.
In this webinar, we will discuss the historical perspective on value in Medical Affairs, as well as strategies to measure and demonstrate impact in an evolving pharmaceutical environment. Join us to learn more about how data-driven strategies can help you gain a better understanding of your Medical Affairs activities and provide insights into areas of opportunity
In this interview recorded at the MAPS 2023 Annual Meeting in Nashville, MAPS speaks with Bill Tidwell, Director, Field Based Medicine | Health System and Payor Strategy at Boehringer Ingelheim about engaging organized customers.
As evidence generation becomes more advanced and integrated into Medical Affairs strategic plans, there is a greater need to maximize its impact by leveraging emerging digital technologies to communicate complex clinical and nonclinical data.
In this episode, listeners will better understand what innovative content is in the context of Medical Information while setting expectations of HCPs in accessing innovative content.
This webinar examines, based on the prevailing pre-launch situation, the strategic focus areas for Medical Affairs teams to consider during launch preparation and discuss approaches to achieve excellence across key activities.
Advisory boards bring together a selection of key opinion leaders to discuss a topic important to a life sciences company. Here is how to use engagement technologies to generate actionable insights from your next ad board.
The session focuses on results from first hand experiences in Chat GPT and other Large Language Models (LLMs).
